NEW YORK (GenomeWeb News) – Arizona’s Translational Genomics Research Institute said yesterday that it has spun out a new company that will offer a data resource for clinical oncologists that will include genetic information discovered by TGen.
Based in Scottsdale, MedTrust Online will be a web-based resource that will serve as a “one-stop medical information resource” for oncologists, the company said.
The new company will offer information about potential drug therapies and a consultation service allowing doctors to discuss difficult cases with experts.
MedTrust said that cancer care provider South Texas Oncology and Hematology is helping to develop the MedTrust website, which is expected to launch in December.
MedTrust spun out of TGen Accelerator Management, an LLC aimed at translating TGen’s genetics research into medical treatments and services, TGen said.
MaryAnn Guerra, TGen’s chief business officer and president of TGen Accelerator, said this is the first informatics-focused business spinout for the non-profit institute, and it “marks a beginning in the effort to use the vast knowledge generated by TGen scientists for the commercial benefit of doctors and the general public.”
TGen said it signed a licensing and services agreement with MedTrust Online in early August that covered the use of TGen’s technologies and personnel.
Financial terms of the license agreement were not released.